Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$32,462,575
+$7,593,834 QoQ
Shares Held
27,065
+0.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.20%
of 13F equity value
Holder Rank
#688
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Snowden Capital Advisors LLC holds $146,228,358 across 13 Drug Manufacturers - General names. LLY ranks #1 (22.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
27,065 | $32,462,575 | |
| 2 | ABBV |
AbbVie Inc.
|
120,256 | $30,261,219 | |
| 3 | JNJ |
Johnson & Johnson
|
109,396 | $27,783,302 | |
| 4 | MRK |
Merck & Co., Inc.
|
145,291 | $18,669,893 | |
| 5 | AMGN |
Amgen Inc
|
39,480 | $14,296,497 | |
| 6 | AZN |
Astrazeneca PLC
|
42,309 | $8,022,632 | |
| 7 | NVS |
Novartis AG
|
22,603 | $3,542,342 | |
| 8 | PFE |
Pfizer Inc
|
125,051 | $3,011,228 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,462,575 | 27,065 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $24,868,741 | 27,038 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $32,724,009 | 30,450 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,748,552 | 28,504 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,371,731 | 28,699 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $23,953,867 | 29,003 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $21,654,600 | 28,050 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $28,945,431 | 32,672 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $27,721,830 | 30,619 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $24,125,317 | 31,011 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $13,612,930 | 23,353 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,969,669 | 18,561 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $15,850,586 | 33,798 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,155,233 | 26,659 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,607,324 | 26,261 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,309,124 | 25,697 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $7,570,770 | 23,350 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,272,644 | 18,412 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $830,869 | 3,008 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,035,088 | 8,808 | Shares | Sole | 2024-02-06 | |
| 2021-06-30 | $1,800,354 | 7,844 | Shares | Sole | 2024-01-08 | |
| 2021-03-31 | $1,422,260 | 7,613 | Shares | Sole | 2024-01-08 | |
| 2020-12-31 | $1,048,496 | 6,210 | Shares | Sole | 2024-01-08 | |
| 2020-09-30 | $749,129 | 5,061 | Shares | Sole | 2024-01-08 | |
| 2020-06-30 | $838,959 | 5,110 | Shares | Sole | 2024-01-08 | |
| 2020-03-31 | $605,651 | 4,366 | Shares | Sole | 2024-01-08 | |
| No filing history on record for this holder in this stock. | ||||||